🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying Ulocuplumab combined with ibrutinib as a po...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2017-10-20
Trial ID
NCT03225716
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of BMS-9...
Status
Completed
Location
Uab Comprehensive Cancer Center
Start Date
2010-08
Trial ID
NCT01120457
Treatments Being Tested
Participant that has been diagnosed with Relapsed/ Refractory Multiple Myel...
Status
No Longer Available
Location
Dana Farber Cancer Institute
Start Date
TBD
Trial ID
NCT02666209
Treatments Being Tested
The purpose of this study is to determine 1) the safety and tolerability of...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2011-09
Trial ID
NCT01359657
The purpose of this study is to determine the safety and effectiveness of u...
Status
Terminated
Location
Ucla Center Health Sci
Start Date
2015-01-27
Trial ID
NCT02305563
Treatments Being Tested
The purpose of this study is to determine whether the combination of Ulocup...
Status
Terminated
Location
University Of Colorado Hosp
Start Date
2015-07-13
Trial ID
NCT02472977
Treatments Being Tested